Explore this insightful article and exclusive video with Henlius’ COO to discover:
- Its achievements in biosimilar approvals, including serplulimab, and its anticipated launch into the European market.
- The essential role of strategic partnerships in Henlius’ success, including over 20 global collaborations with Abbott Laboratories, Accord Healthcare, Eurofarma and more.
- An overview of Henlius’ late-stage pipeline drugs, and ambitious plans shaping the future of biosimilars.
Click here to download this Special Report in PDF format